Alimoghaddam K - Search Results

1

Cell-based regenerative therapy as an alternative to liver transplantation for end-stage liver disease: experience from iran.

Malekzadeh R, Mohamadnejad M, Alimoghaddam K, Bagheri M, Baharvand H, Ghavamzadeh A. Malekzadeh R, et al. Among authors: alimoghaddam k. Int J Organ Transplant Med. 2010;1(1):21-7. Epub 2010 Feb 1. Int J Organ Transplant Med. 2010. PMID: 25013559 Free PMC article.

2

Which factors can affect cord blood variables?

Mohyeddin Bonab MA, Alimoghaddam KA, Goliaei ZA, Ghavamzadeh AR. Mohyeddin Bonab MA, et al. Among authors: alimoghaddam ka. Transfusion. 2004 May;44(5):690-3. doi: 10.1111/j.1537-2995.2004.03227.x. Transfusion. 2004. PMID: 15104649

3

Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?

Mohyeddin Bonab M, Alimoghaddam K, Vatandoust S, Forouzia F, Jahani M, Ghavamzadeh A. Mohyeddin Bonab M, et al. Among authors: alimoghaddam k. Transplant Proc. 2004 Dec;36(10):3190-3. doi: 10.1016/j.transproceed.2004.10.088. Transplant Proc. 2004. PMID: 15686726

4

Interaction of arsenic trioxide As2O3 with DNA and RNA.

Nafisi S, Sobhanmanesh A, Alimoghaddam K, Ghavamzadeh A, Tajmir-Riahi HA. Nafisi S, et al. Among authors: alimoghaddam k. DNA Cell Biol. 2005 Oct;24(10):634-40. doi: 10.1089/dna.2005.24.634. DNA Cell Biol. 2005. PMID: 16225394

5

Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.

Ghavamzadeh A, Alimoghaddam K, Ghaffari SH, Rostami S, Jahani M, Hosseini R, Mossavi A, Baybordi E, Khodabadeh A, Iravani M, Bahar B, Mortazavi Y, Totonchi M, Aghdami N. Ghavamzadeh A, et al. Among authors: alimoghaddam k. Ann Oncol. 2006 Jan;17(1):131-4. doi: 10.1093/annonc/mdj019. Epub 2005 Oct 14. Ann Oncol. 2006. PMID: 16227315 Free article.

6

Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemia.

Alimoghaddam K, Shariftabrizi A, Tavangar SM, Sanaat Z, Rostami S, Jahani M, Ghavamzadeh A. Alimoghaddam K, et al. Leuk Lymphoma. 2006 Jan;47(1):81-8. doi: 10.1080/10428190500300373. Leuk Lymphoma. 2006. PMID: 16321832 Clinical Trial.

7

Aging of mesenchymal stem cell in vitro.

Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Bonab MM, et al. Among authors: alimoghaddam k. BMC Cell Biol. 2006 Mar 10;7:14. doi: 10.1186/1471-2121-7-14. BMC Cell Biol. 2006. PMID: 16529651 Free PMC article.

8

Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.

Alimoghaddam K, Ghaffari H, Foroughi F, Chardouli B, Sanaat Z, Bahar B, Mousavi A, Iravani M, Ghavamzadeh A. Alimoghaddam K, et al. Arch Iran Med. 2006 Apr;9(2):99-103. Arch Iran Med. 2006. PMID: 16649348

9

Use of Novoseven for arsenic trioxide-induced bleeding in PML.

Alimoghaddam K, Ghavamzadeh A, Jahani M. Alimoghaddam K, et al. Am J Hematol. 2006 Sep;81(9):720. doi: 10.1002/ajh.20713. Am J Hematol. 2006. PMID: 16804937 Free article. No abstract available.

10

Real-time PCR analysis of PML-RAR alpha in newly diagnosed acute promyelocytic leukaemia patients treated with arsenic trioxide as a front-line therapy.

Ghaffari SH, Rostami S, Bashash D, Alimoghaddam K, Ghavamzadeh A. Ghaffari SH, et al. Among authors: alimoghaddam k. Ann Oncol. 2006 Oct;17(10):1553-9. doi: 10.1093/annonc/mdl150. Epub 2006 Jul 10. Ann Oncol. 2006. PMID: 16831853 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters